GlycoMimetics Inc (NASDAQ:GLYC)
| 8.19 Data as of Jul 31 |  -0.27 / -3.19%Today’s Change | 6.02 Today|||52-Week Range 18.99 | -- Year-to-Date |
Latest GLYC News | Press Releases
No recent news for GlycoMimetics Inc.
Today’s Trading
| Previous close | 8.46 |
| Today’s open | 8.30 |
| Day’s range | -- - -- |
| Volume | 32,107 |
| Average volume (3 months) | 140,000 |
| Market cap | $153.9M |
| Dividend yield | -- |
Data as of 07/31/2014
Growth & Valuation
| Earnings growth (last year) | -272.73% |
| Earnings growth (this year) | +101.24% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -73.83% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 52.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EGRXEagle Pharmaceutical... | -0.16 | -1.43% |
| CPRXCatalyst Pharmaceuti... | -0.03 | -1.30% |
| DRRXDURECT Corp | -0.02 | -1.33% |
| CNCEConcert Pharmaceutic... | -0.25 | -2.97% |
Data as of 07/31/2014
Financials
| Next reporting date | September 3, 2014 |
| EPS forecast (this quarter) | $0.25 |
| Annual revenue (last year) | $4.0M |
| Annual profit (last year) | -$10.6M |
| Net profit margin | -265.63% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Rachel K. King |
Chief Financial Officer & Head-Media Relations Brian M. Hahn |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
.
